Overview

Prevention of COVID-19 Infection to Severe Pneumonia or ARDS

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
A trial of EC-18 in patients with mild/moderate pneumonia due to COVID-19
Phase:
Phase 2
Details
Lead Sponsor:
Enzychem Lifesciences Corporation